Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 5/2018

Ausgabe 5/2018

Inhaltsverzeichnis ( 18 Artikel )

16.08.2018 | Review Article | Ausgabe 5/2018

Liposomal therapies in oncology: does one size fit all?

Isabel Sousa, Filipa Rodrigues, Hugo Prazeres, Raquel T. Lima, Paula Soares

07.08.2018 | Original Article | Ausgabe 5/2018 Open Access

A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors

Mary E. R. O’Brien, Debashis Sarker, Jaishree Bhosle, Kiruthikah Thillai, Timothy A. Yap, Martina Uttenreuther-Fischer, Karine Pemberton, Xidong Jin, Sabrina Wiebe, Johann de Bono, James Spicer

09.08.2018 | Original Article | Ausgabe 5/2018

Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer

Ippokratis Messaritakis, Maria Sfakianaki, Chara Papadaki, Asimina Koulouridi, Nikolaos Vardakis, Filippos Koinis, Dora Hatzidaki, Nefeli Georgoulia, Athina Kladi, Athanasios Kotsakis, John Souglakos, Vassilis Georgoulias

13.08.2018 | Original Article | Ausgabe 5/2018

A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity

Soo Jie Chung, Sung-Yoon Kang, Rae-Young Kang, Young-Chan Kim, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, Hye-Ryun Kang

13.08.2018 | Original Article | Ausgabe 5/2018

Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy

Negin Farshchian, Avisa Alavi, Sahel Heydarheydari, Nasrin Moradian

13.08.2018 | Original Article | Ausgabe 5/2018

In vitro UGT1A1 inhibition by tyrosine kinase inhibitors and association with drug-induced hyperbilirubinemia

Hisham Qosa, Brittany R. Avaritt, Neil R. Hartman, Donna A. Volpe

20.08.2018 | Original Article | Ausgabe 5/2018

Biotransformation of [14C]-ixazomib in patients with advanced solid tumors: characterization of metabolite profiles in plasma, urine, and feces

Sandeepraj Pusalkar, Mihaela Plesescu, Neeraj Gupta, Michael Hanley, Karthik Venkatakrishnan, Jing-Tao Wu, Cindy Xia, Xiaoquan Zhang, Swapan Chowdhury

21.08.2018 | Original Article | Ausgabe 5/2018

Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment

Kelong Tao, Meng He, Feng Tao, Guangen Xu, Minfeng Ye, Yuanyuan Zheng, Yaoqing Li

24.08.2018 | Original Article | Ausgabe 5/2018

A novel TRAIL mutant-TRAIL-Mu3 enhances the antitumor effects by the increased affinity and the up-expression of DR5 in pancreatic cancer

Min Huang, Hong Zhu, Cheng Yi, Juan Yan, Lijia Wei, Xi Yang, Shouchun Chen, Ying Huang

30.08.2018 | Original Article | Ausgabe 5/2018 Open Access

Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane

Hironaga Satake, Tamotsu Sagawa, Koshi Fujikawa, Yukimasa Hatachi, Hisateru Yasui, Masahito Kotaka, Takeshi Kato, Akihito Tsuji

31.08.2018 | Original Article | Ausgabe 5/2018

Effect of cyclosporine coadministration on the pharmacokinetics of eltrombopag in healthy volunteers

Vassilios Aslanis, Jianping Zhang, Barbara Lomeli, Kai Grosch, Taoufik Ouatas

03.09.2018 | Original Article | Ausgabe 5/2018

Changes in plasma interleukin-8 and tumor necrosis factor-α levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinoma

Ayako Iida-Ueno, Masaru Enomoto, Sawako Uchida-Kobayashi, Atsushi Hagihara, Yuga Teranishi, Hideki Fujii, Hiroyasu Morikawa, Yoshiki Murakami, Akihiro Tamori, Le Thi Thanh Thuy, Norifumi Kawada

03.09.2018 | Original Article | Ausgabe 5/2018

Feasibility of 5-fluorouracil pharmacokinetic monitoring using the My-5FU PCM™ system in a quaternary oncology centre

Michael Moloney, David Faulkner, Emma Link, Danny Rischin, Ben Solomon, Annette M. Lim, John R. Zalcberg, Michael Jefford, Michael Michael

04.09.2018 | Original Article | Ausgabe 5/2018

A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement

Elena Fountzilas, Elangovan Krishnan, Filip Janku, Siqing Fu, Daniel D. Karp, Aung Naing, Vivek Subbiah, David S. Hong, Sarina A. Piha-Paul, David J. Vining, Apostolia-Maria Tsimberidou

11.09.2018 | Original Article | Ausgabe 5/2018

Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood

Z. Liu, J. Martin, L. Orme, B. Seddon, J. Desai, W. Nicholls, D. Thomson, D. Porter, G. McCowage, C. Underhill, N. Cranswick, M. Michael, M. Zacharin, A. Herschtal, J. Sivasuthan, D. M. Thomas

29.09.2018 | Clinical Trial Report | Ausgabe 5/2018 Open Access

A randomized, single-blind, single-dose study to assess the pharmacokinetic equivalence of the biosimilar ABP 215 and bevacizumab in healthy Japanese male subjects

Vladimir Hanes, Vincent Chow, Zhiying Pan, Richard Markus

27.08.2018 | Short Communication | Ausgabe 5/2018

A comparison of the quality of informed consent for phase I oncology trials over a 30-year period

Laeeq Malik, James Cooper

01.09.2018 | Correction | Ausgabe 5/2018

Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models

Udai Banerji, Nivedita Sain, Swee Y. Sharp, Melanie Valenti, Yasmin Asad, Ruth Ruddle, Florence Raynaud, Michael Walton, Suzanne A. Eccles, Ian Judson, Ann L. Jackman, Paul Workman

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise